Navigation Links
Changes in Medicare Advantage Reimbursement May Prompt Members to Shop for New Plans
Date:3/31/2009

Deft Research Releases Study showing state of the senior health care market

MINNEAPOLIS, March 31 /PRNewswire/ -- Deft Research recently released the 2009 Senior Market Dynamics Study, which describes switching and shopping behavior in the senior health insurance market.

When premiums go up $15-30, the study found that 45-75% of the Medicare Advantage market will be mobilized to shop for different health insurance. The study found that at a $5 dollar premium increase 20% of MA members would ask their current insurer for alternatives to their current plan, and 17% would look at plans from different insurers. If faced with a change that made them want to switch their plan, 61% of MA members said they would stay in an MA type product, while 18% would choose to have original Medicare only and 21% would choose a MedSupp plan. This willingness to change plans is big news to MA providers, and understanding how hard they can push members before they will look for different insurance will be vital information in this market.

Over 1,500 seniors participated in this study conducted in February and March of 2009. The study asked questions that are responsive to a need to understand consumer behavior under changing premiums and benefits. Recipients of the report will also have the opportunity for a teleconference presentation, and receive follow up research and technical assistance, and monthly Executive Research Briefs.

Last month, the Center for Medicare and Medicaid Services (CMS) announced lower than expected reimbursement for Medicare Advantage plans. "This change will have a dramatic effect how MA plans build and price their products," says Deft Research's Principal Rich Hamer, "Many seniors will see a reduction of benefits, an increase in premium or both. Deft's new Senior Market Dynamics Study looks at the reaction of consumers to these types of changes."

About Def
'/>"/>

SOURCE Deft Research, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mylan Announces Intention to Purchase Remaining Interest in Matrix Laboratories and Delist Matrix from Indian Stock Exchanges
2. Finland Seeks Systemic Changes in Health Care
3. Genetic changes outside nuclear DNA suspected to trigger more than half of all cancers
4. eFoodSafety.com, Inc. Changes Name to Nuvilex, Inc., Reflecting New Strategic Direction of Company
5. BMP Sunstone Exchanges and Calls Outstanding Notes Due May 2009
6. Study finds pay for performance stimulates changes in medical practice
7. Sysmex Corporation Announces Organizational Changes
8. Study finds injectable birth control causes significant weight gain and changes in body mass
9. Nanophase Announces Changes in Principal Officers and Directors
10. Calling Policies Unreasonable, 123 Members of Congress Press for Changes in Medicare Home Oxygen Policies for Emergency Care, Supplies and Other Obligations After 36 Months of Service
11. Lilly Announces Leadership Changes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., $4Million Alliance ProgramSupportsFutureLea...uideAvailableat www.Allia n ceS c h...Newswire/--"Mr.President,youcancountusin.Withourco...isproudtobeapartofEducatetoInnovate,"saidAdolphP.F...ispanicHealth,afterattendingaWhiteHousemeetingtoda...
(Date:11/23/2009)..., CHERRYHILL,N.J.,Nov.23/PRNewswire/--Inasurveyo...icersandChiefFinancialOfficers,72percentdonotbelie...thcaresystem. ,, Accordingtoresultsofthelatests...ll,NJaccountingfirm,theeconomytoppedthelistat85per...129responsestoits1500surveyssenttocompaniesfromall...
(Date:11/23/2009)...vember 23, 2009 -- Exposure shortly after birth to...stion and particles from diesel emissions are asso...ty children, according to a new study by researche...ntal Health (CCCEH) at Columbia University,s Mailm...t to analyze the effects of exposure to airborne m...
(Date:11/23/2009)... iCRco is proud to announce i...y KLAS and received the highest grade possible amo...nufacturer to be rated “A” in sales, s...ustomer satisfaction in software functionality. iC...ghest grade by the most prestigious research firm ...
(Date:11/23/2009)..., MIAMI,Nov.23/PRNewswire/--James.G.Schwade,M.D....bleforcancerpatientsattheCyberKnifeCenterofMiami,(...reatmentforcancerisapreciselytargetedintensedoseof...lincision.Thelengthofthetreatmentcanlastfrom30minu... ,, AsthefirstCyberKnifeTreatmentCenterintheSou...
Breaking Medicine News(10 mins):Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2Health News:Exposures to metals and diesel emissions in air linked to respiratory symptoms in children 2Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 2Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 3
...rove collaboration regarding the emergency managem...ifically bird flu//, a training program was conduc...lving transfer of a suspected case of bird flu fro...Services Department responded immediately to the c...
...or new treatments for many conditions as they have...lt tissue//. But the human embryo stem cell is ent...elieve the human testicle may provide a less contr...great usefulness. The researchers believe similar ...
...o noise, and do not like it much! According to a n...dings// may face an increased risk of suffering a ...d that the chances of urban middle-aged adults, li...gs. All the same, if work environment reverberated...
...control in all the schools of England in a move to...//. There are currently 2,409 nurses who work...ry but the latest announcement signals a massive e...urse working with each small group of state primar...
...r has announced that it will be creating a new 'br... that inadvertently// develops between a doctor an...mplex medical terminology by the latter. This anno...uch information as possible about their disease, b...
...ecome a health hazard today with a magnitude of ab...nternal automatic defibrillators (IAD) have now co...n electrical discharge from these apparatus have b...ese were people who were leading normal lives, wit...
Other Medicine News:Health News:Human Testicular Cells Would Help In Stem Cell Research 2Health News:Seconds Between Life And Death 2
(Date:11/23/2009)..., NOVATO,Calif.,Nov.23/PRNewswire-FirstCall/--Rapt...aq: RPTP ),todayannouncedresultsfromaPhase2bclinic...tartrate("DRCysteamine")inpatientswithnephropathic...iversityofCalifornia,SanDiego("UCSD")GeneralClinic...macokineticsandpharmacodynamicsofasingledoseofDRCy...
(Date:11/23/2009)..., EMERYVILLE,Calif.,Nov.23/PRNewswire-FirstCall/--...TI")announcedtodaythatitsboardofdirectorshasdeclar...ock,whichwillbepaidonDecember9,2009tostockholderso...rdinarydividendfollowsstockholderapprovalofthediss...ddissolutionandanearlierextraordinarydividendof$0....
(Date:11/20/2009)..., WAYNE, Pa., Nov. 20 ...nced the results for its fiscal first quarter ende...r of fiscal 2010, product revenue decreased approx...e three-month period ended September 30, 2009 as c...Company reported the decreased net revenue of $8,4...
Breaking Medicine Technology:Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Number of Underweight Kids in U S Continues to Shrink 51798 1AHIMA Launches New Interactive myPHR com Web Site 51796 1AHIMA Launches New Interactive myPHR com Web Site 51796 2AHIMA Launches New Interactive myPHR com Web Site 51796 3Netsmart Technologies Acquires Pharmacy Management Software Company 51795 1Netsmart Technologies Acquires Pharmacy Management Software Company 51795 2Netsmart Technologies Acquires Pharmacy Management Software Company 51795 3
...titis, the common, chronic, inflammatory skin dise...ng in prevalence over the past two decades and aff...ing to current estimates, approximately 15 percent...d other industrialized countries around the world ...f life. By comparison, only an estimated 3 percent...
...ition- , , -Biologics License Application for Wri...iled Within Two Weeks- , , , EXTON, Pa., March 5...y positive top-line efficacy results from a Phase ...agen Therapy(TM) for the treatment of moderate to ...acy endpoints and was statistically significant, m...
Other Medicine Technology:Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children 2Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children 3Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children 4Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children 5Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 2Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 3Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 4Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 5Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant 6
...r provides effective therapy at an affordable pric...home or on the go and features ease of use, a 5-ye...ave come to count on from DeVilbiss., ,The PulmoA... those patients seeking a quality, effective treat...
...th low to moderate pain in one or more limbs assoc...d back. This may include people with post laminect...isc surgery or degenerative disc disease and Compl...s+ was designed to give patients more control over...
TurboFlow™ System 3000 Insufflator, 10 liter
KLEPPINGER tongs
Medicine Products: